TLR2 and colitis: On the other hand, B. fragilis was shown to be protective against colitis and colitis-induced colorectal cancer by TLR2 signaling via polysaccharide A production (75), which was also found to be responsible for ameliorating abnormal metabolism of the anti-fungal agent voriconazole (76).